Compliance Rate

Compliance Rate 33.0%
Compliant submissions 33
Incompliant submissions 67
Total trials 100

Your Clinical Trials

Showing 25 of 100 entries
View as:

Study 8

Phase: N/A Priority: Normal
NCT ID: NCT00000007 Org: User:
Start: 01/09/22 End: 01/11/22 Due: 01/12/22

Study 18

Phase: N/A Priority: Normal
NCT ID: NCT00000017 Org: User:
Start: 01/19/22 End: 01/21/22 Due: 01/22/22

Study 28

Phase: N/A Priority: Normal
NCT ID: NCT00000027 Org: User:
Start: 01/29/22 End: 01/31/22 Due: 02/01/22

Study 38

Phase: N/A Priority: Normal
NCT ID: NCT00000037 Org: User:
Start: 02/08/22 End: 02/10/22 Due: 02/11/22

Study 48

Phase: N/A Priority: Normal
NCT ID: NCT00000047 Org: User:
Start: 02/18/22 End: 02/20/22 Due: 02/21/22

Study 58

Phase: N/A Priority: Normal
NCT ID: NCT00000057 Org: User:
Start: 02/28/22 End: 03/02/22 Due: 03/03/22

Study 68

Phase: N/A Priority: Normal
NCT ID: NCT00000067 Org: User:
Start: 03/10/22 End: 03/12/22 Due: 03/13/22

Study 78

Phase: N/A Priority: Normal
NCT ID: NCT00000077 Org: User:
Start: 03/20/22 End: 03/22/22 Due: 03/23/22

Study 88

Phase: N/A Priority: Normal
NCT ID: NCT00000087 Org: User:
Start: 03/30/22 End: 04/01/22 Due: 04/02/22

Study 98

Phase: N/A Priority: Normal
NCT ID: NCT00000097 Org: User:
Start: 04/09/22 End: 04/11/22 Due: 04/12/22

Study 248

Phase: N/A Priority: Normal
NCT ID: NCT00000247 Org: User:
Start: 09/06/22 End: 09/08/22 Due: 09/09/22

Study and Treatment of Post Lyme Disease (STOP-LD)

Phase: N/A Priority: Normal
NCT ID: NCT00000937 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

Buprenorphine Detoxification - BBDVI - 19

Phase: N/A Priority: Normal
NCT ID: NCT00000237 Org: User:
Start: 05/31/97 End: - Due: -

Buprenorphine Maintenance for Opiate Dependence - 6

Phase: N/A Priority: Normal
NCT ID: NCT00000357 Org: User:
Start: 06/30/92 End: 10/31/93 Due: 10/31/94

Dietary Intervention Study for Hypertension (DISH)

Phase: N/A Priority: Normal
NCT ID: NCT00000497 Org: User:
Start: 01/31/80 End: 09/30/94 Due: 09/30/95

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00000597 Org: User:
Start: 03/31/82 End: 12/31/88 Due: 12/31/89

The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00000967 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

Phase: N/A Priority: Normal
NCT ID: NCT00000767 Org: User:
Start: - End: 07/31/96 Due: 07/31/97

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000947 Org: User:
Start: - End: 07/31/00 Due: 07/31/01

Pharmacologic Relapse Prevention for Alcoholic Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00000457 Org: User:
Start: 06/30/98 End: 08/31/07 Due: 08/31/08

Preventing the Return of Depression in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000377 Org: User:
Start: 03/31/89 End: 04/30/00 Due: 04/30/01

Effects of Parathyroid Hormone in Men With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00000427 Org: User:
Start: 09/30/99 End: 10/31/05 Due: 10/31/06

A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)

Phase: N/A Priority: Normal
NCT ID: NCT00000727 Org: User:
Start: - End: 08/31/91 Due: 08/31/92

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00000807 Org: User:
Start: - End: 07/31/00 Due: 07/31/01

Enalapril After Anthracycline Cardiotoxicity

Phase: N/A Priority: Normal
NCT ID: NCT00000547 Org: User:
Start: 04/30/94 End: 02/28/01 Due: 02/28/02